Key Insights

Highlights

Success Rate

81% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

10.8%

4 terminated out of 37 trials

Success Rate

81.0%

-5.6% vs benchmark

Late-Stage Pipeline

5%

2 trials in Phase 3/4

Results Transparency

59%

10 of 17 completed with results

Key Signals

10 with results81% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (18)
P 1 (1)
P 2 (1)
P 4 (2)

Trial Status

Completed17
Unknown4
Terminated4
Withdrawn4
Active Not Recruiting4
Recruiting3

Trial Success Rate

81.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT06564636Active Not Recruiting

A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System

NCT02380092Active Not RecruitingPrimary

Post Market Clinical Follow Up of LEGION™ Primary TKS With VERILAST™

NCT06920459Recruiting

Zimmer Biomet Shoulder Arthroplasty PMCF Study

NCT05357378Not ApplicableRecruitingPrimary

Safety and Effectiveness of the HIT Reverse HRS

NCT02686528Not ApplicableCompleted

Postoperative Hip Precautions After Total Hip Arthroplasty Via the Posterior Approach: A Prospective Randomized Trial

NCT06235710Completed

Prevalence of Musculoskeletal Complaints in Nursing Home Residents

NCT07008690Active Not RecruitingPrimary

MRI of the TMJ in Patients With DJD

NCT06948682Not ApplicableCompletedPrimary

Exploring the Relationship Between Occlusion and Degenerative TMJ Disorders: A Comparative Clinical Study

NCT06927934Completed

Postmarketing Multicenter Study of Intra-Articular DIART ONE / EASYGO ONE for Knee Osteoarthritis

NCT03056534CompletedPrimary

R3 Delta Ceramic Acetabular System PAS U.S.

NCT04399928CompletedPrimary

EU Safety and Efficacy Study Regarding the R3 Acetabular Hip System

NCT06506656Not ApplicableRecruitingPrimary

Hyaluronic Acid and Adelmidrol (Hyadrol®) in Patients With Degenerative Joint Disease

NCT02211794Active Not RecruitingPrimary

Journey II BCS EU Observational Trial

NCT03119038Phase 4Withdrawn

Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Replacement

NCT05229458Unknown

Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of HYALEXO

NCT01551472TerminatedPrimary

Post Market Study of the 3DKnee™ With E-plus Insert

NCT04918680Not Yet RecruitingPrimary

Prospective Post-market Study Examining the Effectiveness of the EcoFit®

NCT00819481CompletedPrimary

Post-Market Study of the 3DKnee™ System

NCT03488147Phase 2Withdrawn

Whether Proton Pump Inhibitors, Administered Prior to or After Surgery, Can Reduce the Incidence and/or Severity of Difficulty Swallowing Foods and/or Liquids,Following Anterior Cervical Surgery

NCT03090672Not ApplicableUnknown

Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease

Scroll to load more

Research Network

Activity Timeline